ES2132147T3 - Triazolopiridazinas como antiasmaticos. - Google Patents

Triazolopiridazinas como antiasmaticos.

Info

Publication number
ES2132147T3
ES2132147T3 ES93104367T ES93104367T ES2132147T3 ES 2132147 T3 ES2132147 T3 ES 2132147T3 ES 93104367 T ES93104367 T ES 93104367T ES 93104367 T ES93104367 T ES 93104367T ES 2132147 T3 ES2132147 T3 ES 2132147T3
Authority
ES
Spain
Prior art keywords
optionally substituted
group
activities
optionally
rent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93104367T
Other languages
English (en)
Spanish (es)
Inventor
Akio Miyake
Yasuhiko Kawano
Asuko Ashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2132147T3 publication Critical patent/ES2132147T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
ES93104367T 1992-03-18 1993-03-17 Triazolopiridazinas como antiasmaticos. Expired - Lifetime ES2132147T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6178092 1992-03-18
JP21890492 1992-08-18
JP1456093 1993-02-01

Publications (1)

Publication Number Publication Date
ES2132147T3 true ES2132147T3 (es) 1999-08-16

Family

ID=27280691

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93104367T Expired - Lifetime ES2132147T3 (es) 1992-03-18 1993-03-17 Triazolopiridazinas como antiasmaticos.

Country Status (21)

Country Link
US (1) US5389633A (en:Method)
EP (1) EP0562439B1 (en:Method)
CN (1) CN1040874C (en:Method)
AT (1) ATE181075T1 (en:Method)
AU (1) AU654430B2 (en:Method)
CA (1) CA2091874A1 (en:Method)
DE (1) DE69325199T2 (en:Method)
DK (1) DK0562439T3 (en:Method)
EE (1) EE9400357A (en:Method)
ES (1) ES2132147T3 (en:Method)
FI (1) FI104076B1 (en:Method)
GR (1) GR3030817T3 (en:Method)
HU (2) HU218791B (en:Method)
LT (1) LT3200B (en:Method)
LV (1) LV10456B (en:Method)
MY (1) MY108967A (en:Method)
NO (1) NO300774B1 (en:Method)
NZ (1) NZ247171A (en:Method)
PH (1) PH29998A (en:Method)
RU (1) RU2130458C1 (en:Method)
TW (1) TW255891B (en:Method)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5464853A (en) * 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
US5482939A (en) * 1992-03-18 1996-01-09 Takeda Chemical Industries, Ltd. Triazolopyridazine compounds, their production and use
EP0620224B1 (en) * 1993-04-12 1998-07-15 Takeda Chemical Industries, Ltd. Triazolopyridazine derivatives, their production and use
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
TW304878B (en:Method) * 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd
WO1996008496A1 (en) * 1994-09-16 1996-03-21 Takeda Chemical Industries, Ltd. Triazolopyridazines process and intermediates for their preparation and their use as medicaments
US5977117A (en) * 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) * 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
ATE283270T1 (de) 1997-04-25 2004-12-15 Takeda Chemical Industries Ltd Condensierte pyridazine derivate,deren herstellung und verwendung
EA003993B1 (ru) 1997-04-28 2003-12-25 Инсизив Фармасьютикэлз Инк. Сульфонамиды для лечения заболеваний, связанных с эндотелином
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
WO1999044611A1 (en) * 1998-03-04 1999-09-10 Takeda Chemical Industries, Ltd. Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
US6610694B1 (en) 1998-10-06 2003-08-26 Takeda Chemical Industries, Ltd. Condensed pyridazine compounds, their production and use
ATE256128T1 (de) 1998-10-21 2003-12-15 Takeda Chemical Industries Ltd Kondensierte pyridazinderivate, verfahren zu ihrer herstellung und ihre anwendung
RU2194494C1 (ru) * 2001-04-28 2002-12-20 Общество с ограниченной ответственностью "Абидофарма" Мазь "тамидерм"
KR20100120139A (ko) * 2008-02-05 2010-11-12 사노피-아벤티스 Ｐａｒ１ 억제제로서의 트리아졸륨 염, 이들의 제조방법, 및 약제로서의 용도
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en) 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005057A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) New compounds
WO2013005041A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) Tricyclic heterocyclic compounds as kinase inhibitors
WO2013004984A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncologicas (Cnio) Tricyclic compounds for use as kinase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915968A (en) 1973-09-21 1975-10-28 Lepetit Spa Triazolopyridazines
US4136182A (en) 1976-05-26 1979-01-23 The Dow Chemical Company Triazolopyridazines used to alleviate bronchial spasms
AU593109B2 (en) * 1986-06-05 1990-02-01 Merrell Dow Pharmaceuticals Inc. 2,3-dihydro-1-(8-methyl-1,2,4-triazolo-{4,3-b}pyridazin-6-YL )-4(1H)-pyridinone
PH27291A (en) * 1989-01-31 1993-05-04 Takeda Chemical Industries Ltd Imidazolpyrimidazines their production and use
EP0440119A1 (en) * 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazine compounds, their production and use
EP0444549B1 (en) * 1990-03-01 1995-01-25 Takeda Chemical Industries, Ltd. Imidazopyridazines their production and use

Also Published As

Publication number Publication date
ATE181075T1 (de) 1999-06-15
CA2091874A1 (en) 1993-09-19
FI104076B (fi) 1999-11-15
PH29998A (en) 1996-10-29
MY108967A (en) 1996-11-30
LV10456A (lv) 1995-02-20
NO300774B1 (no) 1997-07-21
DE69325199D1 (de) 1999-07-15
US5389633A (en) 1995-02-14
LTIP390A (lt) 1994-08-25
RU2130458C1 (ru) 1999-05-20
AU3526993A (en) 1993-09-23
HU218791B (hu) 2000-12-28
GR3030817T3 (en) 1999-11-30
NZ247171A (en) 1994-09-27
EE9400357A (et) 1996-04-15
AU654430B2 (en) 1994-11-03
HU211326A9 (en) 1995-11-28
FI931190A7 (fi) 1993-09-19
DK0562439T3 (da) 1999-11-15
CN1077958A (zh) 1993-11-03
HU9300759D0 (en) 1993-06-28
DE69325199T2 (de) 1999-12-16
TW255891B (en:Method) 1995-09-01
EP0562439A1 (en) 1993-09-29
LT3200B (en) 1995-03-27
EP0562439B1 (en) 1999-06-09
HK1009700A1 (en) 1999-06-04
FI931190A0 (fi) 1993-03-17
FI104076B1 (fi) 1999-11-15
HUT65935A (en) 1994-08-29
NO930974L (no) 1993-09-20
LV10456B (en) 1995-10-20
CN1040874C (zh) 1998-11-25
NO930974D0 (no) 1993-03-17

Similar Documents

Publication Publication Date Title
ES2132147T3 (es) Triazolopiridazinas como antiasmaticos.
ES2071334T3 (es) Analogos de anillos fusionados de nitrogeno conteniendo heterociclos no aromaticos.
EP0473084A3 (en) Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides
CO4230233A1 (es) Derivados de benzofurano
DK1022277T3 (da) Nye taxanderivater
DE69111029D1 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
DE69433346D1 (de) Verbindungen verwendbar als Zwischenprodukte zur Herstellung von Piperidinderivate
DE69630214D1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
CO5261559A1 (es) Antagonistas de neurokinina selectivos
DE69716292D1 (de) Benzopyranderivate
MY123467A (en) Preparation of sterically hindered amine ethers
ES2158109T3 (es) Nuevo derivado de indano fusionado y sal del mismo farmaceuticamente aceptable.
MX9301240A (es) Derivados heterociclicos de cetona, condensados, metodo para su produccion y composicion farmaceutica que los contiene.
ES2096413T3 (es) Derivado de acido 5-amino-8-metil-7-pirrolidinilquinoleina-3-carboxilico.
ATE165357T1 (de) Neue verwendung bis-heterocyclische verbindungen und dessen zusammensetzungen
MX9306679A (es) Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene.
ES2087568T3 (es) Esteres aromaticos de fenilendialcanoatos como inhibidores de neutrofilo elastasa humana.
MX9307475A (es) Monofilamentos antimicrobianos para cepillos de dientes.
ES2173182T3 (es) Derivado de 4,6-dl-butil-2,3-dihidrobenzotiofenos como antioxidantes de ldl.
ES2015621A6 (es) Un metodo para preparar compuestos cuaternarios de enamina.
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
CO4950517A1 (es) Procedimiento para la preparacion de 4-sustituido-1h-indol - 3 - glioxamidas
YU27091A (sh) Herbicidni sestavki
ES2104761T3 (es) Derivado de benzotiazol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 562439

Country of ref document: ES